Stockreport

Bristol-Myers Squibb: 'Strong Buy' As 2026 Milestones Could Bolster Its Prospects [Seeking Alpha]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF The company's growth portfolio now nears 60% of total revenues, growing 16% YoY, effectively offsetting impending patent cliff losses. Key pipeline assets iberdomide [Read more]